Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
Prostate cancer (PCa) is the second most common malignancy with an estimation of 1.5 million new cases in 2022, which is account for 14% of total cancer diagnosed in men worldwide(Ferlay J, 2024). Even more worrying is that the number of new cases of PCa …